Does lactoferrin improve survival free from morbidity in very low birth weight infants? Lactoferrin Infant Feeding Trial: a randomised controlled trial
Does lactoferrin improve survival free from morbidity in very low birth weight infants? Lactoferrin Infant Feeding Trial: a randomised controlled trial
University of Sydney
1,500 participants
Jun 18, 2014
Interventional
Conditions
Summary
A two arm randomised controlled trial in more than 1500 preterm babies less than 1500 grams to compare standard feeding regimens versus adding BLF to feeds on the incidence of death and major disability in VLBW infants.
Eligibility
Inclusion Criteria1
- Babies are eligible if (a) <1500 g birth weight (b) less than or equal to 7 days old and expected to survive and (c) parent gives written informed consent.
Exclusion Criteria1
- Babies with severe congenital anomalies which are likely to cause death are not eligible
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bovine Lactoferrin (BLF): Dosage - 200 mg/kg/day added to breast milk or formula, once daily. Study intervention is administered until 34 weeks corrected gestation or for 2 weeks, whichever is longer, or until discharge home, if earlier.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000247976